LDL levels and ejection fraction in ischemic stroke patients: a hospital based cross-sectional study

Soumya K. Das; A. Thomas Edwin Raj; Y. Kingsly Jebasingh; B. Kannan; Hrishikesh S. Pai

doi:10.18203/2320-6012.ijrms20233984

Authors

Soumya K. Das Department of Neuromedicine, Government Thoothukudi Medical College, Thoothukudi, Tamil Nadu, India
A. Thomas Edwin Raj Department of Neuromedicine, Government Thoothukudi Medical College, Thoothukudi, Tamil Nadu, India
Y. Kingsly Jebasingh Department of Neuromedicine, Government Thoothukudi Medical College, Thoothukudi, Tamil Nadu, India
B. Kannan Department of Neuromedicine, Government Thoothukudi Medical College, Thoothukudi, Tamil Nadu, India
Hrishikesh S. Pai Department of Neuromedicine, Government Thoothukudi Medical College, Thoothukudi, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20233984

Keywords:

Ejection fraction, Ischemic stroke, LDL levels

Abstract

Background: Ischemic stroke is a top contributor to mortality amongst non-infectious diseases. Atherosclerosis is a major risk factor. This study aims to assess LDL levels and ejection fraction in ischemic stroke patients.

Methods: This descriptive cross-sectional study was conducted in Government Thoothukudi Medical College from November, 2022 to April, 2023. 35 patients admitted in the neuromedicine ward and diagnosed as acute ischemic stroke were included in the study after informed consent and ethical clearance. Patients with acute neurological deficit and evidence of infarct on diffusion-weighted MRI were included. Patients with no evidence of infarct on DWI, those already on lipid lowering therapy, patients with a history of cerebrovascular disease or transient ischemic attacks were excluded. Blood for lipid profile taken after 8 hours of overnight fasting. Echocardiography done for all patients.

Results: Of the 35 patients, 26 (74.28%) were men, mean age was 62.4. 57.14% ischemic stroke patients had their LDL levels elevated, 28.57% had decreased HDL, 28.57% had total cholesterol levels elevated, and in 14.28% triglycerides was elevated. This study also observed the cardiac status of the patients which showed 29% patients had decreased ejection fraction.

Conclusions: This study concluded that most patients had elevated LDL levels which is an independent risk factor of ischemic cerebrovascular disease. LDL levels were also associated with decreased ejection fraction in a significant number of patients. Thereby it can be concluded that elevated LDL cholesterol levels can add to the cardiac risk, potentially contributing to stroke morbidity and mortality.

Metrics

Metrics Loading ...

References

Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Executive summary: heart disease and stroke statistics-2011 update. Circulation. 2011;123(4):459-63.

Bejot Y, Daubail B, Giroud M. Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives. Rev Neurol (Paris) 2016;172(1):59-68.

Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8(5):453-63.

Glasser SP, Mosher A, Howard G, Banach M. What is the association of lipid levels and incident stroke? Int J Cardiol. 2016;220:890-4.

Bushnell CD. Stroke and the female brain. Nat Clin Pract Neurol. 2008;4(1):22-33.

Keene D, Price C, Shun-Shin MJ, Francis DP. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014;349:g4379.

Koren-Morag N, Tanne D, Graff E, Goldbourt U, Bezafibrate Infarction Prevention Study Group. Low-and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch In Med. 2002;162(9):993-9.

Amarenco P, Goldstein LB, Callahan III A, Sillesen H, Hennerici MG, O’Neill BJ, et al. Baseline blood pressure, low-and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atheroscler. 2009;204(2):515-20.

Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082-90.

Vergouwen MD, De Haan RJ, Vermeulen M, Roos YB. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke. 2008;39(2):497-502.

Hassan M, Farid-Ud-Din Ah, Farogh A. Comparison of serum LDL levels in ischemic & hemorrhagic stroke. Pakistan J Med Heal Sci. 2014;8(4).

Mahmood A, Sharif MA, Khan MN, Ali UZ. Comparison of serum lipid profile in ischaemic and haemorrhagic stroke. J Coll Physicians Surg Pak. 2010;20(5):317-20.

Sulehria SB, Asrar A, Qureshi IH. Comparison of lipid profile in thrombotic and hemorrhagic stroke patients. Ann King Edw Medi Univer. 2005;11(4).

Jain M, Jain A, Yerragondu N, Brown RD, Rabinstein A, Jahromi BS, et al. The triglyceride paradox in stroke survivors: a prospective study. Neurosci J. 2013;2013.

Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, et al. Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol. 2009;66(11):1400-6.

Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S. Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274-83.

Sung PH, Chen KH, Lin HS, Chu CH, Chiang JY, Yip HK. The correlation between severity of neurological impairment and left ventricular function in patients after acute ischemic stroke. J Clin Medi. 2019;8(2):190.

Mayala HA, Mafuru M, Mkangala A, Mayala M, Pallangyo P, Minja D, et al. Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease. BMC Res Notes. 2020;13(1):1-6.